Shuyun Rao, Ph.D.
Affiliations: | 2010 | University of Miami, Coral Gables, FL |
Area:
Molecular Biology, Oncology, Cell BiologyGoogle:
"Shuyun Rao"Parents
Sign in to add mentor| Kerry L. Burnstein | grad student | 2010 | University of Miami | |
| (Vav3 potentiation of androgen receptor activity in prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Xiang X, Ohshiro K, Zaidi S, et al. (2022) Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 36: e22335 |
| Rao S, Ohshiro K, Zaidi S, et al. (2020) Tu1661 RESISTANCE TO FATTY LIVER DISEASE, NAFLD AND NASH WITH HCC IN HOMOZYGOUS LIVER SPECIFIC CONDITIONAL LOSS OF TGF-β/SMAD3 ADAPTOR PROTEIN SPTBN1 Gastroenterology. 158 |
| Gu S, Zaidi S, Hassan MI, et al. (2019) Mutated CEACAMs Disrupt Transforming Growth Factor beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology |
| Rao S, Peri S, Hoffmann J, et al. (2019) RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance. Plos One. 14: e0222392 |
| Ohshiro K, Zaidi S, Korkut A, et al. (2019) Abstract 3382: A pan-cancer analysis reveals high frequency genetic alterations in mediators of signaling by the TGF-β superfamily Cancer Research. 79: 3382-3382 |
| Rao S, Zaidi S, Jogunoori W, et al. (2019) Abstract 4360: ALDH2 and the TGF-β/SMAD3 adaptor, Sptbn1 suppress hepatic steatosis and obesity Cancer Research. 79: 4360-4360 |
| Rao S, King CH, Mazumder R, et al. (2019) Abstract 2827: Identification of chemotherapeutic resistant microbiota profile in colorectal cancer Cancer Research. 79: 2827-2827 |
| Rao S, Shetty K, Deng C, et al. (2019) Mo1435 – Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer Gastroenterology. 156: S-1306 |
| Gu S, Rao S, King CH, et al. (2019) 628 – Identification of Crosstalk Between Gut Microbiota, Ceacams, and TGF-Β Signaling in Processing Chemotherapy Response in Colon Cancer Gastroenterology. 156: S-132 |
| Rao S, Mishra L. (2018) Targeting TGF-β signaling in Liver Cancer. Hepatology (Baltimore, Md.) |